Work

Development of a Nanoliposomal Formulation of Erlotinib for Lung Cancer and in vitro/In vivo Antitumoral Evaluation [Retraction]

Year: 2022
Type: article
Abstract: [This retracts the article DOI: 10.2147/DDDT.S146925.].
Authors: Xiao Zhou, Hui Tao, Kai-Hu Shi
Language: English
Subfield: Biomaterials
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W4309616026
FWCI:
Cites:
Cited by: 1
Related to: 10